Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. As of July 19, 2026, the company's share repurchase plan had accumulated 137.502 million shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.21% of the company's total share capital. The highest purchase price was RMB 70.00 yuan/share, and the lowest price was RMB 45.30 per share. The total amount paid was RMB 853 million (excluding transaction fees).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.